DAS
ABBV icon

Daybright Advisory Services’s AbbVie ABBV Stock Holding History

Daybright Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349K Buy
1,391
+54
+4% +$11.6K 0.08% 110
2026
Q1 		$291K Buy
1,337
+3
+0.2% +$665 0.08% 114
2025
Q4 		$305K Buy
+1,334
New +$304K 0.08% 109

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Daybright Advisory Services's ABBV Position: Q2 2026 in Review

Daybright Advisory Services increased its AbbVie (ABBV) stake by 4% in Q2 2026, buying an estimated $11.6K and bringing the position to 1,391 shares worth $349K. The position accounts for 0.08% of the portfolio, ranked #110.

Daybright Advisory Services first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Daybright Advisory Services held 1,391 shares of AbbVie worth $349K as of Q2 2026.
  • Daybright Advisory Services bought 54 AbbVie shares in Q2 2026, an estimated $11.6K.
  • AbbVie made up 0.08% of Daybright Advisory Services's portfolio in Q2 2026, its #110 holding.
  • Daybright Advisory Services first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Daybright Advisory Services's 13F filing for Q2 2026, filed 4 Aug 2026.